| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/11/1997 | EP0777728A1 Polycystic kidney disease 1 gene and uses thereof |
| 06/11/1997 | EP0777690A1 Monoclonal antibodies against human colon carcinoma-associated antigens and uses therefor |
| 06/11/1997 | EP0777689A1 Cytadherence peptides for use in modifying mutual adhesion among eukaryotic cells |
| 06/11/1997 | EP0777688A1 New immunocontraceptive peptides |
| 06/11/1997 | EP0777687A1 Trefoil peptide dimer |
| 06/11/1997 | EP0777686A1 Trophic factors for central nervous system regeneration |
| 06/11/1997 | EP0777685A1 Antigenic peptides derived from the g protein of rsv for type- and subtype-specific diagnosis of respiratory syncytial virus (rsv) infection |
| 06/11/1997 | EP0777684A1 Calcitonin receptor |
| 06/11/1997 | EP0777681A2 Cyclic cs-1 peptidomimetics, compositions and methods of using the same |
| 06/11/1997 | EP0777679A1 Delivery of nucleic acids |
| 06/11/1997 | EP0777678A1 Pna combinatorial libraries and improved methods of synthesis |
| 06/11/1997 | EP0777677A1 Methods of identifying compounds useful for treating autoimmune diseases |
| 06/11/1997 | EP0777499A1 Live vaccine for the treatment of tumour diseases |
| 06/11/1997 | EP0777494A1 Human chemokine polypeptides |
| 06/11/1997 | EP0777493A1 Calcitonin gene related peptide receptor |
| 06/11/1997 | EP0777490A1 Mutant enterotoxin effective as a non-toxic oral adjuvant |
| 06/11/1997 | EP0777489A1 Low molecular yeast active substance extract and process for preparing the same |
| 06/11/1997 | EP0777485A1 2',5' phosphorothioate/phosphodiester oligoadenylates and antiviral uses thereof |
| 06/11/1997 | EP0777458A1 Control of hair growth |
| 06/11/1997 | EP0607186B1 Macrophage activating factor from animal vitamin d-binding protein |
| 06/11/1997 | EP0472706B1 Induction of protection against viral infection |
| 06/11/1997 | EP0446315B1 Process for the preparation of pai-2 |
| 06/11/1997 | EP0394409B1 Macrophage-derived inflammatory mediator (mip-2) |
| 06/11/1997 | CN1151760A Serum paraoxonase |
| 06/11/1997 | CN1151759A Antibodies which bind to insect jut proteins and their use |
| 06/11/1997 | CN1151758A Novel growth of differentiation factor of the TGF- 'beta' family |
| 06/11/1997 | CN1151700A Tri-, tetra-, penta- and polypeptides and their therapeutic use as an antidepressant agent |
| 06/11/1997 | CN1151406A Method for purifying thrombomodulin |
| 06/10/1997 | US5637785 Genetically modified plants having modulated flower development |
| 06/10/1997 | US5637686 Tata-binding protein associated factor, nucleic acids |
| 06/10/1997 | US5637682 Genetic engineering |
| 06/10/1997 | US5637677 Biologically active compounds and methods of constructing and using the same |
| 06/10/1997 | US5637575 Orally administering liquid composition comprising water soluble sulfated cyclodextrin derivative and nontoxic carrier |
| 06/10/1997 | US5637567 Method for modifying, diagnosing, and screening for IGF-I sensitive cell barrier properties |
| 06/10/1997 | US5637565 Cocrystallization of different streptogramins |
| 06/10/1997 | US5637562 Isoelectric washing a vegetable protein concentrate; reacting with beta-glucosidase |
| 06/10/1997 | US5637561 Removing glucose molecule from glucones in presence at least one glucosidase, esterase enzymes |
| 06/10/1997 | US5637495 Plasmids for production of human growth hormone or polypeptide analog thereof, hosts containing the plasmids, products manufactured thereby, and related methods |
| 06/10/1997 | US5637493 Carcinoma associated antigen (SK1) monoclonal antibodies against SK1, methods of producing these antibodies and use therefor |
| 06/10/1997 | US5637492 Activatable fibrinolytic and anti-thrombotic proteins |
| 06/10/1997 | US5637487 Genetic engineered polypeptide; used for immunization of chickens against coccidiosis |
| 06/10/1997 | US5637481 Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell |
| 06/10/1997 | US5637480 DNA molecules encoding bone morphogenetic protein-10 |
| 06/10/1997 | US5637479 Genetic engineering |
| 06/10/1997 | US5637471 Therapeutic and diagnostic methods and compositions based on transducin-like enhancer of split proteins and nucleic acids |
| 06/10/1997 | US5637470 Screening array using cells expressing recombinant α and β subunits of the mammalian large-conductance (maxi-K) potassium channel |
| 06/10/1997 | US5637462 Cathepsin C homolog |
| 06/10/1997 | US5637461 Ligands of HIV-1 TAT protein |
| 06/10/1997 | US5637459 Systematic evolution of ligands by exponential enrichment: chimeric selex |
| 06/10/1997 | US5637455 HIV-2 virus variants |
| 06/10/1997 | US5637454 Assays and treatments of autoimmune diseases |
| 06/10/1997 | US5637309 Including carrier composed of combination of cellulose ether or crystalline cellulose with fat, oil, wax, fatty acid, saccharide and/or polyacrylate ester; for intrathecal implantation |
| 06/10/1997 | US5637303 Use of a phospholipase D mutant of Corynebacterium pseudotuberculosis for vaccination |
| 06/10/1997 | US5637300 Contraceptive vaccine comprising a glycosylated 55 kD zona pellucida protein immunogen and method of use of the same in contraception |
| 06/05/1997 | WO1997020218A1 Calcium channel modulator compositions and methods |
| 06/05/1997 | WO1997020078A1 Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| 06/05/1997 | WO1997020077A1 Methods for detecting mutations associated with hypertrophic cardiomyopathy |
| 06/05/1997 | WO1997020063A1 THEREAPEUTIC APPLICATIONS FOR THE ANTI-T-BAM (CD40-L) MONOCLONAL ANTIBODY 5c8 |
| 06/05/1997 | WO1997020062A1 Il-12 p40 subunit fusion polypeptides and uses thereof |
| 06/05/1997 | WO1997020060A1 Conditionally replicating viral vectors and their use |
| 06/05/1997 | WO1997020059A1 Recombinant live vaccine containing feline herpes virus type 1, particularly for treating feline infectious peritonitis |
| 06/05/1997 | WO1997020058A2 PLANT GENE EXPRESSION VECTOR FAMILY BASED ON THE REGULATORY DNA SEQUENCES OF AN ALFALFA H3 HISTONE GENE VARIANT (MsH3g1) |
| 06/05/1997 | WO1997020057A1 Root specific promoters |
| 06/05/1997 | WO1997020056A2 Enhancer-increased gene expression in plants |
| 06/05/1997 | WO1997020055A1 Use of anti-sense sequences to increase responsiveness to gene amplification |
| 06/05/1997 | WO1997020054A1 Recombinant poxvirus-feline infectious peritonitis virus, compositions thereof and methods for making and using them |
| 06/05/1997 | WO1997020051A2 Vectors and methods for gene transfer to cells |
| 06/05/1997 | WO1997020050A1 Therapeutic and diagnostic compositions |
| 06/05/1997 | WO1997020049A1 Human peptide circulating in the blood and possessing insulinotropic properties |
| 06/05/1997 | WO1997020048A2 Modified sfv molecules which mediate adhesion between cells and uses thereof |
| 06/05/1997 | WO1997020047A1 Methods and compositions for the diagnosis and treatment of cancer |
| 06/05/1997 | WO1997020046A1 Dnam, an nk antigen and adhesion molecule of the immunoglobulin superfamily |
| 06/05/1997 | WO1997020045A2 P2u2 PURINERGIC RECEPTOR |
| 06/05/1997 | WO1997020041A1 Method for solubilizing proteins in organic solvents |
| 06/05/1997 | WO1997020038A1 Compositions and methods for site-directed integration into dna |
| 06/05/1997 | WO1997020036A1 Recombinant adenoviruses which express antigens of the transmissible porcine gastroenteritis virus and use thereof in the formulation of vaccines |
| 06/05/1997 | WO1997020033A1 Salmonella vaccines |
| 06/05/1997 | WO1997019956A1 Method for control of functionality during cross-linking of hemoglobins |
| 06/05/1997 | WO1997019955A1 HUMAN HEART CNBr TROPONIN I ISOFORM AND USE OF SAME |
| 06/05/1997 | WO1997019952A1 The ob receptor and methods of diagnosing and treating weight |
| 06/05/1997 | WO1997019704A1 Smooth muscle cell-derived migration factor |
| 06/05/1997 | WO1997019698A1 Diphtheria toxin epitopes |
| 06/05/1997 | WO1997019695A1 Method for treating retinal ganglion cell injury using glial cell line-derived neurotrophic factor (gdnf) protein product |
| 06/05/1997 | WO1997019694A1 Methods for treating photoreceptors using glial cell line-derived neurotrophic factor (gdnf) protein product |
| 06/05/1997 | WO1997017444A3 Novel sperm receptors |
| 06/05/1997 | WO1997015677A3 New strains of bacillus thuringiensis and pesticide composition containing them |
| 06/05/1997 | WO1997014809A3 Novel expression vectors and methods of use |
| 06/05/1997 | WO1997013858A3 Baboon mage-3 homologs, dna encoding the homologs, and a process for their use |
| 06/05/1997 | WO1997012036A3 Bone stimulating factor |
| 06/05/1997 | WO1997007219A3 Genes and proteins controlling cholesterol synthesis |
| 06/05/1997 | DE19651001A1 Mammalian VAT1-homologous protein, derived peptide(s), antibodies and cDNA |
| 06/05/1997 | DE19543265A1 Autoantigene und Verfahren zur Diagnose von Autoimmunkrankheiten Autoantigens and method for diagnosis of autoimmune diseases |
| 06/05/1997 | CA2239012A1 Diphtheria toxin epitopes |
| 06/05/1997 | CA2238943A1 Root specific promoters |
| 06/05/1997 | CA2238829A1 Methods and compositions for the diagnosis and treatment of cancer |
| 06/05/1997 | CA2238579A1 Smooth muscle cell-derived migration factor |
| 06/05/1997 | CA2238569A1 The ob receptor and methods of diagnosing and treating weight |
| 06/05/1997 | CA2238568A1 Method for solubilizing proteins in organic solvents |
| 06/05/1997 | CA2237937A1 Novel purinergic receptor |
| 06/05/1997 | CA2237716A1 Methods for detecting mutations associated with hypertrophic cardiomyopathy |